Williams Elizabeth A, Martin-Pozo Michelle D, Yu Alexis H, Daniels Krystyna, Marks Madeline, O'Connor April, Phillips Elizabeth J
Center for Drug Safety and Immunology, Vanderbilt University Medical Center, 2611 West End Avenue, STE 210, Nashville, TN, United States, 1 615-322-9174.
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
J Med Internet Res. 2025 May 7;27:e63712. doi: 10.2196/63712.
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are genetically mediated, life-threatening reactions usually caused by a medication in adults. These genetic associations promise an opportunity for pre-prescription screening, prevention, and understanding influences at a population level. Importantly, older adults disproportionally face more severe SJS/TEN reactions and higher mortality rates. However, the study of genetic risk and long-term sequelae of SJS/TEN across racially diverse populations and age groups is hampered by many factors, including rarity, social disparities, and trust in health care and providers, impacting access to hospital- and clinic-based research studies.
This paper aims to explore the utility of multiple social media and web-based search tools to increase study enrollment numbers, diversity, and inclusivity of all populations and ages in the SJS Survivor Study.
The community-based SJS/TEN Survivor Study remotely recruited drug-induced SJS/TEN survivors in the United States. The aims were to help determine genetic risk and long-term outcomes of SJS/TEN. Baseline recruitment included advertisements through the SJS Foundation website and American Burn Association newsletter. Two years into the study, in hopes of improving accessibility and enrollment diversity, social media ads were introduced on the Vanderbilt University Medical Center (VUMC) Facebook and Instagram accounts. Posts were created using flyers and 60-second SJS/TEN survivor video vignettes. Finally, we launched a nationwide Google Ad campaign. To understand the impact of the additional online advertising, we measured the change in registration in both the study interest and the effectiveness of implementation of specific social media and web-based search tools before and after implementation.
With the introduction of social media and Google Ads, we report a 48.6% increase in enrollment overall and a 289.5% increase in participation interest. We noticed the ads were accessible to all age groups and notably reported a more even age distribution of enrolled participants from 18 through 74 years, with an average of 15% enrolled in each age category. The largest increase in any age category was seen in the 65- to 74-year-old patients (n=19), with 16.5% of the age distribution. The most significant increase in enrollment and diversity of responses came from Google Ads, with a total of 201 expressions of interest, from 56 enrolled participants, 33% of which self-identified as non-White. VUMC Facebook ads had an enrollment rate of 15.3%, and VUMC Instagram ads saw an enrollment rate of 14.3%.
Social media and web-based search tools differ in their enrollment effectiveness. Google Ads were found to be the most effective advertisement for recruitment in this community-based study. Each of the social media and web-based strategies used increased enrollment numbers, accessibility to more age ranges, and diversity of enrollment. They show promise as tools to improve inclusion and enrollment in rare disease research such as SJS/TEN.
史蒂文斯 - 约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)是由基因介导的、危及生命的反应,在成人中通常由药物引起。这些基因关联为处方前筛查、预防以及在人群层面理解其影响提供了契机。重要的是,老年人面临更严重的SJS/TEN反应且死亡率更高。然而,跨种族人群和年龄组对SJS/TEN的遗传风险和长期后遗症的研究受到诸多因素的阻碍,包括疾病罕见性、社会差异以及对医疗保健和医疗服务提供者的信任问题,这些都影响了参与基于医院和诊所的研究的机会。
本文旨在探讨多种社交媒体和基于网络的搜索工具在增加SJS幸存者研究中所有人群和年龄组的研究入组人数、多样性和包容性方面的效用。
基于社区的SJS/TEN幸存者研究在美国远程招募药物性SJS/TEN幸存者。目的是帮助确定SJS/TEN的遗传风险和长期后果。基线招募包括通过SJS基金会网站和美国烧伤协会时事通讯进行广告宣传。研究进行两年后,为了提高可及性和入组多样性,在范德比尔特大学医学中心(VUMC)的Facebook和Instagram账户上投放了社交媒体广告。帖子使用传单和60秒的SJS/TEN幸存者视频短片制作。最后,我们开展了一项全国性的谷歌广告活动。为了解额外在线广告的影响,我们测量了实施前后研究兴趣登记的变化以及特定社交媒体和基于网络的搜索工具的实施效果。
随着社交媒体和谷歌广告的引入,我们报告总体入组人数增加了48.6%,参与兴趣增加了289.5%。我们注意到所有年龄组都能看到这些广告,并且值得注意的是,登记参与者的年龄分布从18岁到74岁更加均匀,每个年龄类别平均登记率为15%。任何年龄类别中增加最多的是65至74岁的患者(n = 19),占年龄分布的16.5%。入组人数和反应多样性增加最为显著的来自谷歌广告,共有201人表达了兴趣,其中56人登记参与,33%的人自我认定为非白人。VUMC Facebook广告的入组率为15.3%,VUMC Instagram广告的入组率为14.3%。
社交媒体和基于网络的搜索工具在入组有效性方面存在差异。在这项基于社区的研究中,发现谷歌广告是最有效的招募广告。所使用的每种社交媒体和基于网络的策略都增加了入组人数、扩大了更多年龄范围的可及性以及入组的多样性。它们有望成为改善罕见病研究(如SJS/TEN)中的包容性和入组情况的工具。